~~<i id='953C43D7C5'><strike id='953C43D7C5'><tt id='953C43D7C5'><pre id='953C43D7C5'></pre></tt></strike></i>~~

Home» leisure time» comprehensive

comprehensive

author：leisure time 2025-10-02 05:20:26 Page View：32261

Martin Shkreli Securities Fraud Trial — Kevin Hagen/Getty Images

Is this the end of the line for the “pharma bro” with the perpetual smirk?

Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.

“This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA scientists endorse Pfizer/BioNTech Covid
Next article： How one medical school became remarkably diverse

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

1:03JackSmith,thentheDepartmentofJustice'schiefofthePublicIntegritySection,posesforphotoattheDepartm

DIEP, the 'gold standard' of breast reconstruction, is under threat

AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

YichuanCao/SipaUSAGileadSciencessaidMondayitwillacquireCymaBayTherapeuticsfor$4.3billion,addinganewt

WSS

comprehensive

comprehensive

knowledge

explore

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion